PENN Q1 2026 Earnings Steep EPS Miss Amid Operational Headwinds HRMY Q1 2026 Earnings EPS Misses Estimates Stock Dips Dermata Therapeutics DRMA Q1 2026 Earnings Narrower Loss Surprises as PreRevenue Biotech Continues Pipeline Progress CMPX Q1 2026 Earnings Narrowed Loss Beats Estimates Stock Surges 725 GHI Q1 2026 Earnings Significant EPS Miss Amid Narrowing Net Income Ares Management ARES Q1 2026 Earnings EPS Misses Street View but Stock Gains on Resilient Business Trends